GI CONNECT has summarised the highlights of the ASCO 2017 and WCGIC 2017 meetings for you.
Cancers of the liver, small intestine and pancreas tract by Dr. Thomas Winder
GI CONNECT has summarised the highlights of the ASCO 2017 and WCGIC 2017 meetings for you.
Cancers of the liver, small intestine and pancreas tract by Dr. Thomas Winder
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
From sample collection through to diagnostic modalities
Medical experts discuss how to approach sequencing in clinical practice
Medical experts share their insights on testing and treatment
Medical experts discuss safety and efficacy of IO and IO combinations, clinical trial data, and best practice
Expert opinion on the clinical application of artificial intelligence (AI)
Medical experts share insights and review key clinical trials